ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,503,458 | +15.6% | 300,252 | 0.0% | 2.47% | +20.7% |
Q3 2022 | $5,624,000 | -5.7% | 300,252 | 0.0% | 2.04% | +3.4% |
Q2 2022 | $5,963,000 | -43.2% | 300,252 | -14.7% | 1.98% | -14.8% |
Q1 2022 | $10,494,000 | +17.1% | 351,805 | -7.2% | 2.32% | +30.6% |
Q4 2021 | $8,959,000 | – | 379,117 | – | 1.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |